Publications

Aikman, G. G., & Souheaver, G. T. (2008). Use of the Personality Assessment Inventory (PAI) in neuropsychological testing of psychiatric outpatients. Appl Neuropsychol, 15(3), 176-183.

Akimoto, J., Matsumoto, I., Fukuda, T., Haraoka, J., Yamashima, T., & Matsui, M. (2002). Assessment of post-traumatic cognitive impairment using the Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status). Neurotraumatology, 25 (2), 96-102.

Aupperle, R. L., Beatty, W. W., Shelton Fde, N., & Gontkovsky, S. T. (2002). Three screening batteries to detect cognitive impairment in multiple sclerosis. Mult Scler, 8(5), 382-389.

Badenes, D., Casas, L., Cejudo, J., & Aguilar, M. (2008). [Evaluation of the capacity to drive in patients diagnosed of mild cognitive impairment and dementia.]. Neurologia.

Beatty, W. W. (2004). RBANS analysis of verbal memory in multiple sclerosis. Arch Clin Neuropsychol, 19(6), 825-834.

Beatty, W. W., Mold, J. W., & Gontkovsky, S. T. (2003). RBANS performance: influences of sex and education. J Clin Exp Neuropsychol, 25(8), 1065-1069.

Beatty, W. W., Ryder, K. A., Gontkovsky, S. T., Scott, J. G., McSwan, K. L., & Bharucha, K. J. (2003). Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS. Arch Clin Neuropsychol, 18(5), 509-520.

Beglinger, L. J., Duff, K., Van Der Heiden, S., Moser, D. J., Bayless, J. D., Paulsen, J. S., et al. (2007). Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients. Journal of the International Neuropsychological Society, 13, 172-177.

Berry-Kravis, E., Krause, S. E., Block, S. S., Guter, S., Wuu, J., Leurgans, S., et al. (2006). Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol, 16(5), 525-540.

Berry-Kravis, E., Sumis, A., Hervey, C., Nelson, M., Porges, S. W., Weng, N., et al. (2008). Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr, 29(4), 293-302.

Berry-Kravis, E., Sumis, A., Kim, O. K., Lara, R., & Wuu, J. (2008). Characterization of Potential Outcome Measures for Future Clinical Trials in Fragile X Syndrome. J Autism Dev Disord.

Carlozzi, N. E., Horner, M. D., Yang, C., & Tilley, B. C. (2008). Factor analysis of the Repeatable Battery for the Assessment of Neuropsychological Status. Appl Neuropsychol, 15(4), 274-279.

Chianetta, J. M., Lefebvre, M., LeBlanc, R., & Grignon, S. (2008). Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder. Schizophr Res, 105(1-3), 86-94.

Chouinard, S., Stip, E., Poulin, J., Melun, J. P., Godbout, R., Guillem, F., et al. (2007). Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Curr Med Res Opin, 23(3), 575-583.

Chua, M. V., Tsueda, K., & Doufas, A. G. (2004). Midazolam causes less sedation in volunteers with red hair. Canadian Journal of Anesthesia, 51(1), 25-30. Delle Chiaie, R., Salviati, M., Fiorentini, S., & Biondi, M. (2007). Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine. Exp Clin Psychopharmacol, 15(6), 563-568.

Dickerson, F. B., Boronow, J. J., Stallings, C., Origoni, A. E, Cole, S., Leister, F., Krivogorsky, B., Yolken, R. H. (2006) The catecholO-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive geneenvironmental effects in a complex human psychiatric disorder. BipolarDisord, 8, 124–132.

Dickerson, F., Boronow, J. J., Stallings, C., Origoni, A. E., Cole, S. K., & Yolken, R. H. (2004a). Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status. Psychiatry Res, 129(1), 45-53.

Dickerson, F., Boronow, J. J., Stallings, C., Origoni, A. E., Cole, S., & Yolken, R. H. (2004b). Association between cognitive functioning and employment status of persons with bipolar disorder. Psychiatric Services, 55(1), 54-58.

Dickerson, F., Boronow, J. J., Stallings, C., Origoni, A. E., Ruslanova, I., & Yolken, R. H. (2003). Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Archives of General Psychiatry, 60, 466-472.

Dickerson, F. B., Boronow, J. J., Stallings, C., Origoni, A. E., Sullens, A., & Yolken, R. H. (2007). The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia. Schizophr Res, 96(1-3), 87-92.

Dickerson, F., Stallings, C., Origoni, A., Boronow, J., & Yolken, R. (2007). C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res, 93(1-3), 261-265.

Dickerson, F., Stallings, C., Sullens, A., Origoni, A., Leister, F., Krivogorsky, B., et al. (2008). Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder. Brain Behav Immun.

Dittmann, S., Seemuller, F., Schwarz, M. J., Kleindienst, N., Stampfer, R., Zach, J., et al. (2007). Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord, 9(1-2), 63-70.

Duff, K., Beglinger, L. J., Kettmann, J. D., & Bayless, J. D. (2006). Pre- and post-right middle cerebral artery stroke in a young adult: a case study examining the sensitivity of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Appl Neuropsychol, 13(3), 194-200.

Duff, K., Beglinger, L. J., Schoenberg, M. R., Patton, D. E., Mold, J., Scott, J. G., et al. (2005). Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample. J Clin Exp Neuropsychol, 27(5), 565-575.

Duff, K., Humphreys Clark, J. D., O'Bryant, S. E., Mold, J. W., Schiffer, R. B., & Sutker, P. B. (2008). Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: Sensitivity, specificity, and positive and negative predictive powers. Arch Clin Neuropsychol.

Duff, K., Langbehn, D. R., Schoenberg, M. R., Moser, D. J., Baade, L. E., Mold, J., et al. (2006). Examining the repeatable battery for the assessment of neuropsychological status: factor analytic studies in an elderly sample. Am J Geriatr Psychiatry, 14(11), 976-979.

Duff, K., Langbehn, D. R., Schoenberg, M. R., Moser, D. J., Baade, L. E., Mold, J. W., et al. (2008). Normative data on and psychometric properties of Verbal and Visual Indexes of the RBANS in older adults. Clin Neuropsychol, 1-12.

Duff, K., Leber, W. R., Patton, D. E., Schoenberg, M. R., Mold, J. W., Scott, J. G., et al. (2007). Modified scoring criteria for the RBANS figures. Appl Neuropsychol, 14(2), 73-83.

Duff, K., Mold, J. W., & Gidron, Y. (2009). Cognitive functioning predicts survival in the elderly. J Clin Exp Neuropsychol, 31(1), 90-95.

Duff, K., Mold, J. W., & Roberts, M. M. (2008). Walking Speed and Global Cognition: Results from the OKLAHOMA Study. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 15(1), 31-39.

Duff, K., Mold, J. W., Roberts, M. M., & McKay, S. L. (2007). Medical burden and cognition in older patients in primary care: selective deficits in attention. Arch Clin Neuropsychol, 22(5), 569-575.

Duff, K., Patton, D., Schoenberg, M. R., Mold, J., Scott, J. G., & Adams, R. L. (2003). Age- and education-corrected independent normative data for the RBANS in a community dwelling elderly sample. Clin Neuropsychol, 17(3), 351-366.

Duff, K., Schoenberg, M. R., Beglinger, L. J., Moser, D. J., Bayless, J. D., Culp, K. R., et al. (2008). Premorbid intellect and current RBANS performance: discrepancy scores in three geriatric samples. Appl Neuropsychol, 15(4), 241-249.

Duff, K., Schoenberg, M. R., Mold, J. W., Scott, J. G., & Adams, R. L. (2007). Normative and retest data on the RBANS cortical/subcortical index in older adults. J Clin Exp Neuropsychol, 29(8), 854-859.

Duff, K., Schoenberg, M. R., Patton, D., Mold, J., Scott, J. G., & Adams, R. L. (2004). Predicting change with the RBANS in a community dwelling elderly sample. J Int Neuropsychol Soc, 10(6), 828-834.

Duff, K., Schoenberg, M. R., Patton, D. E., Mold, J. W., Scott, J. G., & Adams, R. L. (2008). Predicting Cognitive Change across 3 Years in Community-Dwelling Elders. Clin Neuropsychol, 1-11.

Duff, K., Schoenberg, M. R., Patton, D., Paulsen, J. S., Bayless, J. D., Mold, J., et al. (2005). Regression-based formulas for predicting change in RBANS subtests with older adults. Arch Clin Neuropsychol, 20(3), 281-290.

Ehrenreich, H., Hinze-Selch, D., Stawicki, S., Aust, C., Knolle-Veentjer, S., Wilms, S., et al. (2007). Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry, 12(2), 206-220.

Fenton, W. S., Dickerson, F., Boronow, J. J., Hibbeln, J. R., & Knable, M. (2001). A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. American Journal of Psychiatry, 158, 2071-2074.

Fink, J., McCrea, M., & Randolph, C. (1998). Neuropsychological differentiation of vascular dementia and Alzheimer's disease: A neurocognitive profile approach using a short battery. Journal of the International Neuropsychological Society, 4, 30.

Freilich, B. M., & Hyer, L. A. (2007). Relation of the Repeatable Battery for Assessment of Neuropsychological Status to measures of daily functioning in dementia. Psychol Rep, 101(1), 119-129.

Garcia, C., Leahy, B., Corradi, K., & Forchetti, C. (2008). Component structure of the Repeatable Battery for the Assessment of Neuropsychological Status in dementia. Arch Clin Neuropsychol, 23(1), 63-72.

Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., et al. (2005). Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology, 64(9), 1553-1562.

Gold, J. M., Goldberg, R., McNary, S., Dixon, L., & Lehman, A. (2002). Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry, 159(8), 1395-1402.

Gold, J. M., Queern, C., Iannone, V. N., & Buchanan, R. W. (1999). Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am J Psychiatry, 156(12), 1944-1950.

Goldberg, R., Lucksted, A., McNary, S., Gold, J. M., Dixon, L., & Lehman, A. (2001). Correlates of long-term unemployment among inner-city adults with serious and persistent mental illness. Psychiatric Services, 52(1), 101-103.

Gontkovsky, S. T., Beatty, W. W., & Mold, J. W. (2004). Repeatable Battery for the Assessment of Neuropsychological Status in a normal, geriatric sample. Clinical Gerontologist, 27(3), 79-86.

Gontkovsky, S. T., Mold, J. W., & Beatty, W. W. (2002). Age and educational influences on RBANS index scores in a nondemented geriatric sample. Clin Neuropsychol, 16(3), 258-263.

Harris, J. G., Kongs, S., Allensworth, D., Martin, L., Tregellas, J., Sullivan, B., et al. (2004). Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology, 29(7), 1378-1385.

Hobart, M. P., Goldberg, R., Bartko, J. J., & Gold, J. M. (1999). Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry, 156(12), 1951-1957.

Holzer, L., Chinet, L., Jaugey, L., Plancherel, B., Sofia, C., Halfon, O., et al. (2007). Detection of cognitive impairment with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in adolescents with psychotic symptomatology. Schizophr Res, 95(1-3), 48-53.

Iverson GL, Brooks BL, Haley GM. (2009). Interpretation of the RBANS in inpatient psychiatry: clinical normative data and prevalence of low scores for patients with schizophrenia. Appl Neuropsychol., 16, 31-41.

Juhasz, L. Z., Kemeny, K., Linka, E., Santha, J., & Bartko, G. (2002). A repeatable battery for the assessment of neuropsychological status. Psychiatria Hungarica, 17(2), 131-140.

Juhasz, L. Z., Kemeny, K., Linka, E., Santha, J., & Bartko, G. (2003). [The use of RBANS test (Repeatable Battery for the Assessment of Neuropsychological Status) in neurocognitive testing of patients suffering from schizophrenia and dementia]. Ideggyogy Sz, 56(9-10), 303-308.

Keri, S., & Kelemen, O. (2008). The role of attention and immediate memory in vulnerability to interpersonal criticism during family transactions in schizophrenia. Br J Clin Psychol.

Killam, C., Cautin, R. L., & Santucci, A. C. (2005). Assessing the enduring residual neuropsychological effects of head trauma in college athletes who participate in contact sports. Arch Clin Neuropsychol, 20(5), 599-611.

Kim, E., & Bijlani, M. (2006). A pilot study of quetiapine treatment of aggression due to traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 547-549.

Kotani, S., Sakaguchi, E., Warashina, S., Matsukawa, N., Ishikura, Y., Kiso, Y., et al. (2006). Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res, 56(2), 159-164.

Larson, E., Kirschner, K., Bode, R., Heinemann, A., & Goodman, R. (2005). Construct and predictive validity of the repeatable battery for the assessment of neuropsychological status in the evaluation of stroke patients. J Clin Exp Neuropsychol, 27(1), 16-32.

Larson, E. B., Kirschner, K., Bode, R. K., Heinemann, A. W., Clorfene, J., & Goodman, R. (2003). Brief cognitive assessment and prediction of functional outcome in stroke. Top Stroke Rehabil, 9(4), 10-21.

Lewis, D. A., Cho, R. Y., Carter, C. S., Eklund, K., Forster, S., Kelly, M. A., & Montrose, D. (2008). Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psychiatry, 165, 12, 1585-1593.

Loughland, C. M., Lewin, T. J., Carr, V. J., Sheedy, J., & Harris, A. W. (2007). RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings. Schizophr Res, 89(1-3), 232-242.

Mahncke, H. W., Connor, B. B., Appelman, J., Ahsanuddin, O. N., Hardy, J. L., Wood, R. A., et al. (2006). Memory enhancement in healthy older adults using a brain plasticity-based training program: a randomized, controlled study. Proc Natl Acad Sci U S A, 103(33), 12523-12528.

McKay, C., Casey, J. E., Wertheimer, J., & Fichtenberg, N. L. (2007). Reliability and validity of the RBANS in a traumatic brain injured sample. Arch Clin Neuropsychol, 22(1), 91-98.

McKay, C., Wertheimer, J. C., Fichtenberg, N. L., & Casey, J. E. (2008). The Repeatable Battery for the Assessment of Neuropsychological Status (Rbans): Clinical Utility in a Traumatic Brain Injury Sample. Clin Neuropsychol, 1-14.

McKendrick, A. M., Badcock, D. R., Badcock, J. C., & Gurgone, M. (2006). Motion perception in migraineurs: abnormalities are not related to attention. Cephalalgia, 26(9), 1131-1136.

Meyer, T., Eshelman, A., & Abouljoud, M. (2006). Neuropsychological changes in a large sample of liver transplant candidates. Transplant Proc, 38(10), 3559-3560.

Mikos, A. E., McDowell, B. D., Moser, D. J., Bayless, J. D., Bowers, W. A., Andersen, A. E., et al. (2008). Stability of neuropsychological performance in anorexia nervosa. Ann Clin Psychiatry, 20(1), 9-13.

Mooney, S., Hasssanein, T. I., Hilsabeck, R. C., Ziegler, E. A., Carlson, M., Maron, L. M., et al. (2007). Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch Clin Neuropsychol, 22(2), 175-186.

Moser, D. J., Benjamin, M. L., Bayless, J. D., McDowell, B. D., Paulsen, J. S., Bowers, W. A., et al. (2002). Neuropsychological functioning pretreatment and posttreatment in an inpatient eating disorders program. International Journal of Eating Disorders, 33, 64-70.

Moser, D. J., Hoth, K. F., Robinson, R. G., Paulsen, J. S., Sinkey, C. A., Benjamin, M. L., et al. (2004). Blood vessel function and cognition in elderly patients with atherosclerosis. Stroke, 35(11), 369-372.

Moser, D. J., Robinson, R. G., Hynes, S. M., Reese, R. L., Arndt, S., Paulsen, J. S., et al. (2007). Neuropsychological performance is associated with vascular function in patients with atherosclerotic disease. Arteriscler Thromb Vasc Biol, 27, 141-146.

Moser, R. S., & Schatz, P. (2002). Enduring effects of concussion in youth athletes. Arch Clin Neuropsychol, 17(1), 91-100.

Moser, R. S., Schatz, P., & Jordan, B. D. (2005). Prolonged effects of concussion in high school athletes. Neurosurgery, 57(2), 300-306; discussion 300-306.

NINDS NET-PD. (2007). A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology, 68(1), 20-28.

Olincy, A., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., et al. (2006). Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry, 63(6), 630-638.

Olincy, A., & Stevens, K. E. (2007). Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. Biochem Pharmacol, 74(8), 1192-1201.

Pachet, A. K. (2007). Construct validity of the Repeatable Battery of Neuropsychological Status (RBANS) with acquired brain injury patients. Clin Neuropsychol, 21(2), 286-293.

Patton, D. E., Duff, K., Schoenberg, M. R., Mold, J., Scott, J. G., & Adams, R. L. (2003). Performance of cognitively normal African Americans on the RBANS in community dwelling older adults. Clin Neuropsychol, 17(4), 515-530.

Patton, D., Duff, K., Schoenberg, M., Mold, J., Scott, J., & Adams, R. (2005). Base rates of longitudinal RBANS discrepancies at one- and two-year intervals in community-dwelling older adults. Clin Neuropsychol, 19(1), 27-44. Patton, D. E., Duff, K., Schoenberg, M. R., Mold, J., Scott, J. G., & Adams, R. L. (2006). RBANS index discrepancies: base rates for older adults. Arch Clin Neuropsychol, 21(2), 151-160.

Randolph, C. (1997). Differentiating vascular dementia from Alzheimer's disease: The role of neuropsychological testing. Clinical Geriatrics, 5(8), 77-84.

Randolph, C. (1998). Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). San Antonio: Harcourt, TX: The Psychological Corporation.

Randolph, C., Roberts, J. W., Tierney, M., Mouradian, M. M., & Chase, T. N. (1994). D-Cycloserine treatment of Alzheimer's disease. Alzheimer's Disease and Related Disorders, 8, 198-205.

Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol, 20(3), 310-319.

Roberts, J. S., Barber, M., Brown, T. M., Cupples, L. A., Farrer, L. A., LaRusse, S. A., et al. (2004). Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med, 6(4), 197-203.

Ryder, K. A., Gontkovsky, S. T., McSwan, K. L., Scott, J. G., Bharucha, K. J., & Beatty, W. W. (2002). Cognitive function in Parkinson's disease: Association with anxiety but not depression. Aging, Neuropsychology, and Cognition, 9(2), 77-84.

Schoenberg, M. R., Duff, K., Beglinger, L. J., Moser, D. J., Bayless, J. D., Mold, J., et al. (2008). Retention rates on RBANS memory subtests in elderly adults. J Geriatr Psychiatry Neurol, 21(1), 26-33.

Schubert, M. H., Young, K. A., & Hicks, P. B. (2006). Galantamine improves cognition in schizophrenic patients stabilized on risperidone. Biol Psychiatry, 60(6), 530-533.

Silverberg, N. D., Wertheimer, J. C., & Fichtenberg, N. L. (2007). An effort index for the Repeatable Battery For The Assessment Of Neuropsychological Status (RBANS). Clin Neuropsychol, 21(5), 841-854.

Sorrell, J. H., Zolnikov, B. J., Sharma, A., & Jinnai, I. (2006). Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci, 60(2), 174-181.

Sotil, E. U., Gottstein, J., Ayala, E., Randolph, C., & Blei, A. T. (2009). Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transplantation, 15, 184-192.

Takaiwa, A., Kuwayama, N., Hayashi, N., Kubo, M., Matsui, M., & Endo, S. (2006). [Cognitive function in patients with severe carotid stenosis--evaluation of RBANS, WAIS-R and NART before treatment of carotid revascularization--]. No To Shinkei, 58(8), 681-686.

Verhagen Metman, L., Morris, M. J., Farmer, C., Gillespie, M., Mosby, K., Wuu, J., et al. (2002). Huntington's diease: A randomized, controlled trial using the NMDA-antagonist amantadine. Neurology, 59, 694-699.

Weber, B. (2003). RBANS has reasonable test-retest reliability in schizophrenia. Evid Based Ment Health, 6(1), 22.

Weber, B. (2003). RBANS has reasonable test-retest reliability in schizophrenia. Evid Based Ment Health, 6(1), 22.

Wilde, M. C. (2006). The validity of the repeatable battery of neuropsychological status in acute stroke. Clin Neuropsychol, 20(4), 702-715.

Wilk, C. M., Gold, J. M., Bartko, J. J., Dickerson, F., Fenton, W. S., Knable, M., et al. (2002). Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. Am J Psychiatry, 159(5), 838-844.

Wilk, C. M., Gold, J. M., Humber, K., Dickerson, F., Fenton, W. S., & Buchanan, R. W. (2004). Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status. Schizophr Res, 70(2-3), 175-186.

Wilson, J.S., Mruthinti, S., Buccafusco, J. J., Schade, R. F., Mitchell, M. B., Harrell, D. U., Gulati, N. K., Miller, S. L. (2009). Anti-RAGE and A{beta} Immunoglobulin Levels Are Related to Dementia Level and Cognitive Performance. J Gerontol A Biol Sci Med Sci, 64(2), 264-71.

Yamashima, T., Yoshida, M., Kumahashi, K., Matsui, M., Koshino, Y., Higashima, M., et al. (2002). [The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status)]. No To Shinkei, 54(6), 463-471.